Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-25 Purchase | 2022-11-29 4:11 pm | Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer | 10,000 | $1.43 | $14,300 | 24,481 (Direct) | View |
| 2021-03-23 Purchase | 2021-03-23 12:24 pm | Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer | 965 | $10.34 | $9,980 | 14,481 (Direct) | View |
| 2020-05-14 Purchase | 2020-05-18 4:17 pm | Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer | 6,993 | $1.43 | $10,000 | 13,369 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-07 Option Award | 2024-03-07 6:39 pm | N/A 2034-03-07 | Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer | 510,000 | $0 | 2,170,310 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 5:41 pm | N/A 2033-03-15 | Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer | 482,064 | $0 | 1,664,477 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-10 6:39 pm | N/A 2032-03-09 | Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer | 370,128 | $0 | 1,185,400 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:11 pm | N/A 2031-06-10 | Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer | 435,072 | $0 | 815,272 (Direct) | View |
| 2021-01-02 Exercise | 2021-01-05 4:03 pm | N/A N/A | Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer | 260 | $0 | 13,516 (Direct) | View |
| 2021-01-02 Tax Withholding | 2021-01-05 4:03 pm | N/A N/A | Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer | 113 | $0 | 13,516 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 4:15 pm | N/A 2030-06-17 | Cardiff Oncology Inc. | CRDF | Erlander Mark Chief Executive Officer | 221,241 | $0 | 380,200 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-03 4:15 pm | N/A N/A | Trovagene Inc. | TROV | Erlander Mark Chief Scientific Officer | 261 | $0 | 6,636 (Direct) | View |
| 2020-01-03 Tax Withholding | 2020-01-03 4:15 pm | N/A N/A | Trovagene Inc. | TROV | Erlander Mark Chief Scientific Officer | 116 | $0 | 6,636 (Direct) | View |
| 2020-01-01 Exercise | 2020-01-03 4:10 pm | N/A N/A | Trovagene Inc. | TROV | Erlander Mark Chief Scientific Officer | 1,250 | $0 | 6,752 (Direct) | View |
| 2020-01-03 Tax Withholding | 2020-01-03 4:10 pm | N/A N/A | Trovagene Inc. | TROV | Erlander Mark Chief Scientific Officer | 552 | $0 | 6,752 (Direct) | View |